4-[8-(2,6-dichloro-4-cyanoanilino)-2-(oxolan-3-ylamino)purin-9-yl]cyclohexane-1-carboxamide
C23H24Cl2N8O2 — CID 121254514
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[8-(2,6-dichloro-4-cyanoanilino)-2-(oxolan-3-ylamino)purin-9-yl]cyclohexane-1-carboxamide
4-[8-(2,6-dichloro-4-cyanoanilino)-2-(oxolan-3-ylamino)purin-9-yl]cyclohexane-1-carboxamide (PubChem CID 121254514) has the molecular formula C23H24Cl2N8O2 and a molecular weight of 515.41 g/mol. Its IUPAC name is 4-[8-(2,6-dichloro-4-cyanoanilino)-2-(oxolan-3-ylamino)purin-9-yl]cyclohexane-1-carboxamide.
Molecular Properties
| Compound Name | 4-[8-(2,6-dichloro-4-cyanoanilino)-2-(oxolan-3-ylamino)purin-9-yl]cyclohexane-1-carboxamide |
|---|---|
| PubChem CID | 121254514 |
| Molecular Formula | C23H24Cl2N8O2 |
| Molecular Weight | 515.41 g/mol |
| Exact Mass | 514.14 |
| IUPAC Name | 4-[8-(2,6-dichloro-4-cyanoanilino)-2-(oxolan-3-ylamino)purin-9-yl]cyclohexane-1-carboxamide |
| SMILES | N#Cc1cc(Cl)c(Nc2nc3cnc(NC4CCOC4)nc3n2C2CCC(C(N)=O)CC2)c(Cl)c1 |
| InChI | InChI=1S/C23H24Cl2N8O2/c24-16-7-12(9-26)8-17(25)19(16)31-23-30-18-10-28-22(29-14-5-6-35-11-14)32-21(18)33(23)15-3-1-13(2-4-15)20(27)34/h7-8,10,13-15H,1-6,11H2,(H2,27,34)(H,30,31)(H,28,29,32) |
| InChIKey | VUALDXCOPIJQFN-UHFFFAOYSA-N |
| XLogP | 4.17 |
| TPSA | 143.77 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 515.41 |
| LogP ≤ 5 | 4.17 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121254514 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.